BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6747629)

  • 1. Dopamine synthesis in synaptosomes: relation of autoreceptor functioning to pH, membrane depolarization, and intrasynaptosomal dopamine content.
    Saller CF; Salama AI
    J Neurochem; 1984 Sep; 43(3):675-88. PubMed ID: 6747629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of dopamine synthesis inhibition by dopamine autoreceptor activation in striatal synaptosomes with in vivo reserpine administration.
    Tissari AH; Lillgäls MS
    J Neurochem; 1993 Jul; 61(1):231-8. PubMed ID: 8099951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is inhibition of striatal synaptosomal tyrosine hydroxylation by dopamine agonists a measure of dopamine autoreceptor function?
    Fowler CJ; Thorell G; Andersson M; Magnusson O
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):12-9. PubMed ID: 2866447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals.
    el Mestikawy S; Glowinski J; Hamon M
    J Neurochem; 1986 Jan; 46(1):12-22. PubMed ID: 2866232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice.
    L'hirondel M; Chéramy A; Godeheu G; Artaud F; Saiardi A; Borrelli E; Glowinski J
    Brain Res; 1998 May; 792(2):253-62. PubMed ID: 9593923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal synaptosomal dopamine synthesis: evidence against direct regulation by an autoreceptor mechanism.
    Compton DR; Johnson KM
    Eur J Pharmacol; 1985 Apr; 110(2):157-62. PubMed ID: 2859213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apomorphine enantiomers' effects on dopamine metabolism: receptor and non-receptor related actions.
    Saller CF; Salama AI
    Eur J Pharmacol; 1986 Feb; 121(2):181-8. PubMed ID: 3699091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]Dopamine release by d-amphetamine from striatal synaptosomes of reserpinized rats.
    Masuoka DT; Alcaraz AF; Schott HF
    Biochem Pharmacol; 1982 Jun; 31(11):1969-74. PubMed ID: 7115417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of protein carboxylmethylation and dopamine autoreceptor functioning.
    Saller CF; Salama AI
    Eur J Pharmacol; 1985 Apr; 111(1):17-22. PubMed ID: 4018124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptosomal dopamine autoreceptors: sensitivity changes after in vitro and in vivo treatments.
    Tissari AH
    Pharmacol Res Commun; 1988 Nov; 20(11):1001-11. PubMed ID: 2853876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
    Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that amphetamine and Na+ gradient reversal increase striatal synaptosomal dopamine synthesis through carrier-mediated efflux of dopamine.
    Connor CE; Kuczenski R
    Biochem Pharmacol; 1986 Sep; 35(18):3123-30. PubMed ID: 3092833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist and antagonist effects of 3-PPP enantiomers on functional dopamine autoreceptors and postsynaptic dopamine receptors in vitro.
    Mulder AH; Draper R; Sminia P; Schoffelmeer AN; Stoof JC
    Eur J Pharmacol; 1985 Jan; 107(3):291-7. PubMed ID: 3979429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of arachidonic acid on dopamine synthesis, spontaneous release, and uptake in striatal synaptosomes from the rat.
    L'hirondel M; Chéramy A; Godeheu G; Glowinski J
    J Neurochem; 1995 Mar; 64(3):1406-9. PubMed ID: 7861174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that adenosine A2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes.
    Onali P; Olianas MC; Bunse B
    Brain Res; 1988 Jul; 456(2):302-9. PubMed ID: 2905190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of apomorphine and bradykinin on uptake and release of dopamine in vitro by striatal synaptosomes of the rat.
    Borawska M; Wiśniewski K
    Pol J Pharmacol Pharm; 1982; 34(1-3):79-84. PubMed ID: 7167424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes.
    Bowyer JF; Spuhler KP; Weiner N
    J Pharmacol Exp Ther; 1984 Jun; 229(3):671-80. PubMed ID: 6726652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the Ca++-evoked release of [3H]dopamine from striatal synaptosomes by dopamine (D2) agonists and antagonists.
    Bowyer JF; Weiner N
    J Pharmacol Exp Ther; 1987 Apr; 241(1):27-33. PubMed ID: 3572788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of dopamine synthesis in synaptosomes from rats treated with neuroleptics or reserpine.
    Tissari AH
    Med Biol; 1982 Feb; 60(1):38-41. PubMed ID: 6121960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of presynaptic receptors in the release and synthesis of 3H-dopamine by slices of rat striatum.
    Westfall TC; Besson MJ; Giorguieff MF; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(3):279-87. PubMed ID: 181686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.